These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10853135)

  • 21. Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer.
    Aillères N; Azria D; Thézenas S; Barbier N; Fenoglietto P; Delard R; Hay MH; Dubois JB
    Cancer Radiother; 2004 Apr; 8(2):59-69. PubMed ID: 15063872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of late side-effects of conformal and conventional radiotherapy in locally limited prostatic carcinoma. A prospective randomized study].
    Feldmann HJ
    Strahlenther Onkol; 1999 Jul; 175(7):350-1. PubMed ID: 10433000
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy.
    Sanghani MV; Ching J; Schultz D; Cormack R; Loffredo M; McMahon E; Beard C; D'Amico AV
    Urol Oncol; 2004; 22(3):165-8. PubMed ID: 15271308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
    Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer.
    Bayley AJ; Catton CN; Haycocks T; Kelly V; Alasti H; Bristow R; Catton P; Crook J; Gospodarowicz MK; McLean M; Milosevic M; Warde P
    Radiother Oncol; 2004 Jan; 70(1):37-44. PubMed ID: 15036850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CTV margins in prostate cancer irradiation. In regard to Teh et al.: IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease (Int J Radiat Oncol Biol Phys 2003;56:184-191).
    Macias V
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):320-1; author reply 321-2. PubMed ID: 15093933
    [No Abstract]   [Full Text] [Related]  

  • 27. Dynamic conformal arc radiotherapy with rectum hollow-out technique for localized prostate cancer.
    Tomita N; Kodaira T; Tachibana H; Nakamura T; Tomoda T; Nakahara R; Inokuchi H; Hayashi N; Fuwa N
    Radiother Oncol; 2009 Mar; 90(3):346-52. PubMed ID: 18950880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity.
    Karlsdóttir A; Muren LP; Wentzel-Larsen T; Dahl O
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1478-86. PubMed ID: 18060703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Australia-wide comparison of intensity modulated radiation therapy prostate plans.
    Skala M; Holloway L; Bailey M; Kneebone A
    Australas Radiol; 2005 Jun; 49(3):222-9. PubMed ID: 15932465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative radiation treatment for rectal cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning.
    Cella L; Ciscognetti N; Martin G; Liuzzi R; Punzo G; Solla R; Farella A; Salvatore M; Pacelli R
    Med Dosim; 2009; 34(1):75-81. PubMed ID: 19181259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. When should the seminal vesicles be included in the target volume in prostate radiotherapy?
    Bayman NA; Wylie JP
    Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):302-7. PubMed ID: 17448647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
    Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809.
    Hurwitz MD; Halabi S; Ou SS; McGinnis LS; Keuttel MR; Dibiase SJ; Small EJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):814-9. PubMed ID: 18407435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rectal dose reduction using three-dimensional conformal radiotherapy for locally advanced prostate cancer: A combination of conformal dynamic-arc and five-static field technique.
    Sasaoka M; Nishikawa A; Futami T; Nishida K; Miwa H; Kadoya K
    Radiother Oncol; 2009 Mar; 90(3):318-24. PubMed ID: 19008004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late rectal and urinary toxicity from conformal, dose-escalated radiation therapy for prostate cancer: a prospective study of 402 patients.
    Lin C; Turner S; Mai T; Kneebone A; Gebski V
    Australas Radiol; 2007 Dec; 51(6):578-83. PubMed ID: 17958696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the technical aspects of hypofractionated radiation therapy treatment of prostate cancer: a review.
    Clemente S; Nigro R; Oliviero C; Marchioni C; Esposito M; Giglioli FR; Mancosu P; Marino C; Russo S; Stasi M; Strigari L; Veronese I; Landoni V
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):182-95. PubMed ID: 25835624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-dimensional conformal radiation therapy for early prostate cancer.
    Peschel RE
    Cancer J Sci Am; 1999; 5(3):145-6. PubMed ID: 10367168
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparing dosimetric, morbidity, quality of life, and cancer control outcomes after 3D conformal, intensity-modulated, and proton radiation therapy for prostate cancer.
    Pearlstein KA; Chen RC
    Semin Radiat Oncol; 2013 Jul; 23(3):182-90. PubMed ID: 23763884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.